Atrium Therapeutics, Inc. (RNA) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 285.56M | 272.85M | 271.26M | 1.25B | 1.43B | 1.54B | 1.62B | 1.33B | 934.47M | 611.31M | 555.49M | 594.53M |
| Cash & Short-Term Investments | 267.85M | 270M | 270M | 1.18B | 1.38B | 1.5B | 1.59B | 1.3B | 915.87M | 595.35M | 542.58M | 576.5M |
| Cash Only | 267.85M | 270M | 270M | 243.91M | 254.2M | 219.87M | 370.19M | 575.75M | 471.4M | 185.08M | 85.65M | 153.88M |
| Short-Term Investments | 0 | 0 | 0 | 939.24M | 1.13B | 1.28B | 1.22B | 723.29M | 444.47M | 410.27M | 456.93M | 422.62M |
| Accounts Receivable | 15M | 0 | 0 | 8.54M | 36.58M | 28.22M | 19.21M | 15.71M | 9.04M | 8.62M | 1M | 1.18M |
| Days Sales Outstanding | 68.75 | - | - | 533.68 | 1.85K | 733.9 | 687.72 | 550.76 | 226.83 | 201.85 | 35.63 | 42.89 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 138K | 1.31M | 0 | 58.88M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.86M |
| Total Non-Current Assets | 6.79M | 5.51M | 6.28M | 118.37M | 24.1M | 21.61M | 18.91M | 18.62M | 17M | 17.25M | 17.68M | 16.25M |
| Property, Plant & Equipment | 6.38M | 5.51M | 6.28M | 24.76M | 20.57M | 18.29M | 15.79M | 15.46M | 16.28M | 16.65M | 17.04M | 15.53M |
| Fixed Asset Turnover | 3.30x | 0.15x | 0.80x | 0.17x | 0.08x | 0.17x | 0.15x | 0.13x | 0.22x | 0.13x | 0.17x | 0.15x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 415K | 0 | 0 | 2.8M | 0 | 0 | 0 | 2.79M | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 90.81M | 3.53M | 3.32M | 3.11M | 364K | 720K | 596K | 639K | 719K |
| Total Assets | 292.36M | 278.35M | 277.54M | 1.37B | 1.46B | 1.56B | 1.64B | 1.35B | 951.47M | 628.55M | 573.16M | 610.78M |
| Asset Turnover | 0.07x | 0.00x | 0.02x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Asset Growth % | -79.96% | -82.2% | -83.08% | 1.6% | 53.35% | 148.81% | 186.27% | 120.61% | 54.97% | -1.6% | 33.13% | 45.15% |
| Total Current Liabilities | 21.91M | 41.8M | 31.74M | 135.06M | 84.86M | 98.02M | 91.33M | 84.21M | 74.95M | 80.68M | 48.72M | 45.24M |
| Accounts Payable | 807K | 4.4M | 451K | 3.91M | 6.63M | 8.46M | 7.66M | 8.89M | 2.35M | 8.81M | 5.55M | 5.65M |
| Days Payables Outstanding | 1.55K | - | - | 3.47 | - | - | - | 744.29 | 792.03 | 1.07K | 10.8 | 10.19 |
| Short-Term Debt | 2.68M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 9.34M | 21.64M | 19.12M | 13.54M | 13.98M | 20.99M | 19.66M | 26.7M | 26.1M | 28.36M | 0 | 0 |
| Other Current Liabilities | 6.98M | 3.15M | 2.59M | 95.24M | 12.81M | 3.66M | 18.24M | 32.03M | 7.8M | 14.34M | 1.97M | 3.81M |
| Current Ratio | 13.04x | 6.53x | 8.55x | 9.26x | 16.91x | 15.73x | 17.76x | 15.78x | 12.47x | 7.58x | 11.40x | 13.14x |
| Quick Ratio | 13.04x | 6.53x | 8.55x | 9.26x | 16.91x | 15.73x | 17.76x | 15.78x | 12.47x | 7.58x | 11.40x | 13.14x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 36.35M | 29.27M | 32.95M | 41.2M | 45.49M | 40.92M | 46.06M | 42.18M | 45.62M | 47.11M | 6.98M | 6.36M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 312K | 1.21M | 2.09M | 2.96M | 3.8M | 4.62M | 5.42M | 6.21M | 6.98M | 6.36M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 574K | 574K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Total Liabilities | 58.26M | 71.07M | 64.69M | 176.26M | 130.35M | 138.94M | 137.39M | 126.39M | 120.58M | 127.79M | 55.7M | 51.61M |
| Total Debt | 2.68M | 3.67M | 4.28M | 5.13M | 5.97M | 6.8M | 7.6M | 8.38M | 9.15M | 9.85M | 10.58M | 9.51M |
| Net Debt | -265.17M | -266.33M | -265.72M | -238.77M | -248.23M | -213.07M | -362.59M | -567.37M | -462.25M | -175.23M | -75.07M | -144.37M |
| Debt / Equity | 0.01x | 0.02x | 0.02x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | 0.02x | 0.02x | 0.02x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 234.1M | 207.29M | 212.85M | 1.19B | 1.33B | 1.42B | 1.5B | 1.22B | 830.9M | 500.76M | 517.47M | 559.18M |
| Equity Growth % | -82.38% | -85.45% | -85.84% | -2.32% | 59.91% | 184.56% | 190.53% | 118.36% | 48.66% | -13.37% | 37.27% | 49.37% |
| Book Value per Share | 13.69 | 12.11 | 1.54 | 9.20 | 10.28 | 11.09 | 12.19 | 11.42 | 9.53 | 6.58 | 6.98 | 7.83 |
| Total Shareholders' Equity | 234.1M | 207.29M | 212.85M | 1.19B | 1.33B | 1.42B | 1.5B | 1.22B | 830.9M | 500.76M | 517.47M | 559.18M |
| Common Stock | 16K | 17K | 17K | 12K | 12K | 12K | 12K | 11K | 10K | 8K | 7K | 7K |
| Retained Earnings | 12.13M | 0 | 0 | -1.17B | -1.01B | -893.07M | -790.81M | -710.41M | -639.62M | -570.76M | -510.32M | -457.96M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 1.78M | 2.77M | 2.9M | 7.1M | -453K | -464K | 125K | -1.88M | -2.67M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |